Journey Medical (DERM) Assets Average (2021 - 2026)
Journey Medical's (DERM) quarterly Assets Average came in at $93.1 million in Q1 2026, up 12.66% YoY from $82.6 million in Q1 2025, and up 3.53% on a QoQ basis from $89.9 million in Q4 2025.
Journey Medical (DERM) Assets Average (2021 - 2026) Analysis & Trends
Journey Medical (DERM) has 6 years of Assets Average data on file, last reported at $93.1 million in Q1 2026.
- Quarterly Assets Average rose 12.66% year-over-year to $93.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $93.1 million (up 12.66% YoY) and the FY2025 annual result came in at $87.4 million, up 11.29% from the prior year.
- Assets Average advanced to $93.1 million in Q1 2026, from $89.9 million in the prior quarter.
- In the past five years, Assets Average ranged from a high of $117.2 million in Q2 2022 to a low of $64.6 million in Q3 2024.
- A 5-year average of $86.6 million and a median of $83.1 million in 2025 frame the typical range for Assets Average.
- Annual changes were most pronounced in 2023 — Assets Average sank 38.79% — and 2025, when it rose 28.72%.
- Tracing DERM's Assets Average over 5 years: stood at $106.7 million in 2022, then plunged by 33.07% to $71.4 million in 2023, then advanced by 1.06% to $72.1 million in 2024, then increased by 24.6% to $89.9 million in 2025, then rose by 3.53% to $93.1 million in 2026.
- The last three Assets Average figures came in at $93.1 million (Q1 2026), $89.9 million (Q4 2025), and $83.2 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.91 Bn | 42.95 Bn | - | 43.72 Bn |
| 2 | Teva Pharmaceutical Industries | 43.07 Bn | 39.42 Bn | 2.15 Bn | 39.95 Bn |
| 3 | Zoetis | 31.54 Bn | 29.86 Bn | 1.05 Bn | 15.12 Bn |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | 98.59 Bn |
| 5 | United Therapeutics | 22.19 Bn | 19.53 Bn | 683.80 Mn | 6.97 Bn |
| 6 | Viatris | 18.68 Bn | 17.79 Bn | 1.46 Bn | 35.94 Bn |
| 7 | Neurocrine Biosciences | 15.50 Bn | 15.11 Bn | 935.80 Mn | 5.13 Bn |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn | 13.39 Bn |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.96 Bn | - | 5.97 Bn |
| 10 | Journey Medical | 205.79 Mn | 180.15 Mn | 12.37 Mn | 94.95 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 94.95 Mn |
| Mar 31, 2026 | 93.06 Mn |
| Dec 31, 2025 | 89.89 Mn |
| Sep 30, 2025 | 83.17 Mn |
| Jun 30, 2025 | 83.06 Mn |
| Mar 31, 2025 | 82.60 Mn |
| Dec 31, 2024 | 72.14 Mn |
| Sep 30, 2024 | 64.62 Mn |
| Jun 30, 2024 | 65.88 Mn |
| Mar 31, 2024 | 71.71 Mn |
| Dec 31, 2023 | 71.38 Mn |
| Sep 30, 2023 | 67.83 Mn |
| Jun 30, 2023 | 82.80 Mn |
| Mar 31, 2023 | 100.51 Mn |
| Dec 31, 2022 | 106.65 Mn |
| Sep 30, 2022 | 110.82 Mn |
| Jun 30, 2022 | 117.20 Mn |
| Mar 31, 2022 | 109.09 Mn |
| Dec 31, 2021 | 93.17 Mn |